4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-20-063615
Executive Vice President sold 40,000 shares at an average $30.81 ($1,232,528)
- Executive Vice President acquired 40,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Holsinger Leslie · Executive Vice President
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-14 | Exercise or conversion : show line 1 in the form | +40,000 | $0.27 | $10,800 | 43,500 | D |
| 2020-12-14 | Sale : show line 2 in the form | −1,700 | $28.80 | $48,960 | 41,800 | D |
| 2020-12-14 | Sale : show line 3 in the form | −14,275 | $30.15 | $430,391 | 27,525 | D |
| 2020-12-14 | Sale : show line 4 in the form | −13,200 | $30.91 | $408,012 | 14,325 | D |
| 2020-12-14 | Sale : show line 5 in the form | −9,525 | $31.79 | $302,800 | 1,800 | D |
| 2020-12-14 | Sale : show line 6 in the form | −400 | $32.59 | $13,034 | 4,400 | D |
| 2020-12-14 | Sale : show line 7 in the form | −900 | $32.59 | $29,331 | 3,500 | D |
| Open-market sales · 40,000 sh · avg $30.81 · $1,232,528 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-11 | Grant or award : show line 8 in the form Stock Option (Right to Buy) | +100,000 | 100,000 | D |
| 2020-12-11 | Grant or award : show line 9 in the form Stock Option (Right to Buy) | +100,000 | 100,000 | D |
| 2020-12-14 | Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) | −40,000 | 66,794 | D |
Loading xslF345X03/doc4.xml…